arginine has been researched along with Agranulocytosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Pauw, BE; Du Bois, W; Verhagen, C; Williams, KJ | 1 |
Carreras, E; Grañena, A; Marín, P; Olivé, MT; Rozman, C; Sierra, J | 1 |
Babare, R; Carbone, A; Lazzarini, R; Merola, MC; Monfardini, S; Talamini, R; Tirelli, U; Zagonel, V | 1 |
1 trial(s) available for arginine and Agranulocytosis
Article | Year |
---|---|
Ceftazidime sodium carbonate versus ceftazidime arginine as empirical monotherapy in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Arginine; Bacterial Infections; Carbonates; Ceftazidime; Clinical Trials as Topic; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Middle Aged; Neutropenia; Prospective Studies; Random Allocation | 1988 |
2 other study(ies) available for arginine and Agranulocytosis
Article | Year |
---|---|
[VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Drug Evaluation; Female; Humans; Leukemia, Lymphoid; Male; Podophyllotoxin; Teniposide | 1984 |
Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy.
Topics: Age Factors; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Infection Control; Length of Stay; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Safety; Teniposide; Treatment Outcome; Vincristine | 1994 |